Research & Development

Chengdu Pioneer Drug Development Co., Ltd. announced a multi-year, long-term, new drug research and development collaboration with Aduro Biotech to achieve a new small...

FDA Approval Of CaroSpir Announced By CMP Pharma , Inc.

CMP Pharma announced that the US FDA has granted final approval of the company’s NDA for CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first...

Takeda and Molecular templates announce research and collaboration to develop next-generation oncology therapies

Research & Development

Takeda Pharma and Molecular Templates, Inc. announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular Templates’ETB technology platform to...

X4 Pharmaceuticals Announces Rare Disease Research Collaboration with Yale University

Research & Development

X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat cancer and rare diseases,...

Is 2017 set to be the year we see a CAR-T therapy approved? Let’s find out from the leaders in the field

Research & Development

Using your body’s own cells, engineering them to target tumors and cure cancer sounds like something from a Sci-Fi movie but it’s not, it’s...

Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358

Research & Development

Eli Lilly and Company and Nektar Therapeutics have announced a strategic collaboration to co-develop NKTR-358, a novel immunological therapy discovered by Nektar. NKTR-358, which...

AMO Pharma Enters into Development and License Agreement with Numedicus ltd

Research & Development

AMO Pharma Limited , a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, announced it has entered into...

Subscribe Our Newsletter

White Papers

Whitepapers

Research & Development

About us

Resources

Advertise

Subscribe